Clinical Information and Biospecimen Collection from Patients with Recurrent or Stage IV Breast Cancer

Recruiting in Palo Alto (17 mi)

+17 other locations

Overseen byKarthik V Giridhar

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Mayo Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial collects clinical information and tissue and blood samples from patients with breast cancer that has come back or is stage IV. Collecting clinical information and biospecimen samples to create a registry may help doctors better understand the mechanism of tumor spread and determine why people respond differently to specific cancer treatments.

Eligibility Criteria

Inclusion Criteria

Histologically confirmed or suspected invasive breast cancer

Radiographic evidence of distant metastatic disease

Clinical or radiographic evidence of disease progression OR presenting with de novo stage IV disease

+7 more

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Observational (biospecimen, clinical info collection)Experimental Treatment2 Interventions

Patients' archival and newly collected tissue and blood samples are collected periodically for genetic testing. Patients also undergo collection of clinical information within 30 days of biopsy procedure and every 4 months.